9-ING-41

Research use only, not for human use.

9-ING-41 is a glycogen synthase kinase-3 inhibitor.9-ING-41 (2, 4 μM; 48 hours) decreases neuroblastoma cell viability induces apoptosis[2]. 9-ING-41 (0.1-1 μM) inhibits GSK-3 leading to a decreased expression of the NF-κB target XIAP and significant apoptosis in neuroblastoma cells as shown by PARP cleavage, an apoptosis marker[1]. 9-ING-41 (0.5, 1.0, 1.5, 2.0 μM) inhibits the proliferation rate of all TCL and MCL lines with concentrations as low as 1.0 mM.

9-ING-41 is a glycogen synthase kinase-3 inhibitor.9-ING-41 (2, 4 μM; 48 hours) decreases neuroblastoma cell viability induces apoptosis. 9-ING-41 (0.1-1 μM) inhibits GSK-3 leading to a decreased expression of the NF-κB target XIAP and significant apoptosis in neuroblastoma cells as shown by PARP cleavage, an apoptosis marker. 9-ING-41 (0.5, 1.0, 1.5, 2.0 μM) inhibits the proliferation rate of all TCL and MCL lines with concentrations as low as 1.0 mM. 9-ING-41 (1, 2 μM; 24 hours) is a potent cell cycle-blocking agent for lymphoma cells[2].9-ING-41 (40 mg/kg/every other day; for 17 days) has single-agent antitumor activity in a mouse model of MCL.

Cell Viability Assay Cell Line:TCL and MCL lines Concentration:2, 4 μM Incubation Time:48 hours Result:Induced apoptosis.Cell Cycle Analysis Cell Line:Lymphoma cells (Jeko, Mino, and OCI-Ly cell lines) Concentration:1, 2 μM Incubation Time:24 hours Result:Led to cell cycle arrest in G2/M.Cell Autophagy Assay Cell Line:T24 cancer cells Concentration:25?μM Incubation Time:24?hours Result:Showed extensive vacuolation and formation of autophagosome like structures in the cytoplasm.Showed an increased expression of LC3, an autophagy marker.Western Blot Analysis Cell Line:SK-N-DZ and SK-N-BE neuroblastoma cells Concentration:0.1, 1 μM Incubation Time:48 hours Result:Inhibited GSK-3 leading to a decreased expression of the NF-κB target XIAP.

Animal Model:NSG (NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ) mice Dosage:40 mg/kg Administration:Every other day; for 17 days Result:Had single-agent antitumor activity in a mouse model of MCL.

——

PI3K/Akt/mTOR signaling

GSK-3

GSK-3β

Others

Myelofibrosis

1034895-42-5

404.35

C22H13FN2O5

>98% (HPLC)

DMSO:97 mg/mL (239.89mM; Need ultrasonic)

Cn1cc(C2=C(C(=O)NC2=O)c2coc3ccc(F)cc23)c2cc3OCOc3cc12

——

(-20℃)

With Ice Pack

≥ 2 years